Rhtalgorism Delay Sprays For Men Liquid
NDC Package 85277-002-01
Package Information
Rhtalgorism Delay Sprays For Men (panax ginseng root extract 7%) liquids is its main function is to reduce local sensitivity, thereby prolonging sexual intercourse time to a certain extent and improving sexual satisfaction. This formulation utilizes a liquid delivery system. Marketed by Guangdong Meizhiyuan Biotechnology Co., Ltd., this product is identified by NDC 85277-002 and is authorized under FDA application 505G(a)(3).
Identification & Billing
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 85277 - Guangdong Meizhiyuan Biotechnology Co., Ltd.
- 85277-002 - Rhtalgorism Delay Sprays For Men
- 85277-002-01 - 6 mL in 1 BOTTLE
- 85277-002 - Rhtalgorism Delay Sprays For Men
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (85277-002). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 85277-002-01 identifies a specific commercial package of 6 ml in 1 bottle of Rhtalgorism Delay Sprays For Men, a human over the counter drug labeled by Guangdong Meizhiyuan Biotechnology Co., Ltd.. This liquid is formulated for topical use and contains asian ginseng; cervus elaphus velvet; cnidium monnieri fruit; epimedium brevicornu top; piper methysticum root; polygonatum odoratum root; rehmannia glutinosa root as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Guangdong Meizhiyuan Biotechnology Co., Ltd. on April 20, 2026. The current certification is valid through December 31, 2027.
How is this Guangdong Meizhiyuan Biotechnology Co., Ltd. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 85277000201. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.